Why the CDC shouldn't hide vaccine data — no matter how ripe for abuse
If you've spent much time exploring vaccine safety concerns, you've likely heard of the Vaccine Adverse Event Reporting System (VAERS), a database run by the Centers for Disease Control and Prevention (CDC) to which anyone can submit a report of a suspected vaccine reaction. If you got a COVID-19 vaccine, you may have received a handout, like I did, explaining how to use VAERS.
The database seems like a smart idea. It's intended to serve as a warning system, a digital canary, to detect patterns of bad side effects before many people are harmed. It's difficult to imagine opposing such a database in theory.
But in practice, VAERS gets a bit messy. You see, not only can anyone make a report or access reams of raw data, but the entries aren't verified before publication. Indeed, as a lengthy VAERS disclaimer explains, "[v]accine providers are encouraged to report any clinically significant health problem following vaccination to VAERS, whether or not they believe the vaccine was the cause," and "reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable." Though obviously fake, trollish accounts are deleted (and knowing false reporting is a crime), some fabricated reports may be published.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And though VAERS provides a guide to interpreting its data alongside that disclaimer, whom among us is naive enough to think every user reads it? Realistically, some subset of those accessing VAERS draw uninformed and incorrect conclusions from the data. Frankly, I think there's a real chance I might misread it myself.
So here's the conundrum: If you make a database like this unregulated and accessible to the public, you're inviting bad data and false conclusions. Just this week, a family member sent me a document from Robert F. Kennedy Jr.'s anti-vaccine organization which relies significantly on VAERS to make an ill-supported case that childhood vaccinations are responsible for an "epidemic of poor health in American children."
But if you regulate VAERS content or make access more exclusive — well, that's awfully suspicious, isn't it? What are they hiding? I'm very pro-vaccine, but even I would be skeptical if VAERS went private or suddenly started screening its reports. Those changes have their supporters: A Harvard Political Review article in April suggested VAERS "in its current form" may do "more harm than good," and a story on VAERS from anti-misinformation organization First Draft praised an Australian system of only publishing adverse reaction accounts that pass scrutiny from a medical professional.
On balance, I think the current, open approach is the better of these two options. There are risks to trusting people with information, but it's preferable to elite censorship or lies by omission. Still, I can't deny I'm uneasy about the problem of public data VAERS exemplifies. Are we stuck forever with a choice between data chaos and control?
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Bonnie Kristian was a deputy editor and acting editor-in-chief of TheWeek.com. She is a columnist at Christianity Today and author of Untrustworthy: The Knowledge Crisis Breaking Our Brains, Polluting Our Politics, and Corrupting Christian Community (forthcoming 2022) and A Flexible Faith: Rethinking What It Means to Follow Jesus Today (2018). Her writing has also appeared at Time Magazine, CNN, USA Today, Newsweek, the Los Angeles Times, and The American Conservative, among other outlets.
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
The bird flu fight is faltering
Talking Points Are pandemic lessons going unheeded?
By Joel Mathis, The Week US Published
-
OTC birth control arrives amid the battle over reproductive rights
Talking Points Opill will cost $19.99 a month. Democrats are pushing to make it cheaper.
By Joel Mathis, The Week US Published
-
What Florida is — and isn't — doing to curb the biggest measles outbreak in the US
Talking Points DeSantis appointee defies expert consensus to stop the spread
By Joel Mathis, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
No, it's not over
Talking Point New Omicron subvariants are headed our way
By William Falk Published